Literature DB >> 34169944

CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.

Yiren Cao1, Jinjun Wu1, Bo Pang1, Hongquan Zhang1, X Chris Le1.   

Abstract

The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crossliene">nker from a molecular traene">nsducer, which facilitated the assembly of gold naene">noparticles. Iene">ntegratioene">n of the molecular traene">nsducer with isothermal amplificatioene">n aene">nd CRISPR/Cas12a resulted iene">n visual detectioene">n of the n class="Gene">N gene and E gene of SARS-CoV-2 in 45 min.

Entities:  

Year:  2021        PMID： 34169944     DOI： 10.1039/d1cc02546e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  11 in total

1.  The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.

Authors:  Juan Lou; Bin Wang; Junwei Li; Peng Ni; Yuefei Jin; Shuaiyin Chen; Yuanlin Xi; Rongguang Zhang; Guangcai Duan
Journal:  Mol Biol Rep       Date:  2022-07-20       Impact factor: 2.742

Review 2.  Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments.

Authors:  Niaz Mahmud; Muzahidul I Anik; M Khalid Hossain; Md Ishak Khan; Shihab Uddin; Md Ashrafuzzaman; Md Mushfiqur Rahaman
Journal:  ACS Appl Bio Mater       Date:  2022-05-18

3.  CLEVER assay: A visual and rapid RNA extraction-free detection of SARS-CoV-2 based on CRISPR-Cas integrated RT-LAMP technology.

Authors:  Akansha Bhatt; Zeeshan Fatima; Munindra Ruwali; Chitra Seetharam Misra; Shyam Sunder Rangu; Devashish Rath; Ashok Rattan; Saif Hameed
Journal:  J Appl Microbiol       Date:  2022-04-18       Impact factor: 4.059

Review 4.  SARS-CoV-2 in wastewater: From detection to evaluation.

Authors:  Danwei Zhang; Solco S Faye Duran; Wei Yang Samuel Lim; Chee Kiang Ivan Tan; Wun Chet Davy Cheong; Ady Suwardi; Xian Jun Loh
Journal:  Mater Today Adv       Date:  2022-01-25

Review 5.  Nanotechnology-based approaches in the fight against SARS-CoV-2.

Authors:  Alrayan Abass Albaz; Misbahuddin M Rafeeq; Ziaullah M Sain; Wael Abdullah Almutairi; Ali Saeed Alamri; Ahmed Hamdan Aloufi; Waleed Hassan Almalki; Mohammed Tarique
Journal:  AIMS Microbiol       Date:  2021-10-12

6.  Accuracy of clustered regularly interspaced short palindromic repeats (CRISPR) to diagnose COVID-19, a meta-analysis.

Authors:  Song Wang; Jiayi Hu; Chuanying Sui; Guangliang He; Zihan Qu; Xiaofei Chen; Yashan Wang; Dingjie Guo; Xin Liu
Journal:  Microb Pathog       Date:  2022-03-25       Impact factor: 3.848

7.  CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles.

Authors:  María López-Valls; Carmen Escalona-Noguero; Ciro Rodríguez-Díaz; Demian Pardo; Milagros Castellanos; Paula Milán-Rois; Carlos Martínez-Garay; Rocío Coloma; Melanie Abreu; Rafael Cantón; Juan Carlos Galán; Rodolfo Miranda; Álvaro Somoza; Begoña Sot
Journal:  Anal Chim Acta       Date:  2022-03-22       Impact factor: 6.911

8.  A CRISPR-Cas12a integrated SERS nanoplatform with chimeric DNA/RNA hairpin guide for ultrasensitive nucleic acid detection.

Authors:  Bohan Yin; Qin Zhang; Xinyue Xia; Chuanqi Li; Willis Kwun Hei Ho; Jiaxiang Yan; Yingying Huang; Honglian Wu; Pui Wang; Changqing Yi; Jianhua Hao; Jianfang Wang; Honglin Chen; Siu Hong Dexter Wong; Mo Yang
Journal:  Theranostics       Date:  2022-08-08       Impact factor: 11.600

Review 9.  AuNP-based biosensors for the diagnosis of pathogenic human coronaviruses: COVID-19 pandemic developments.

Authors:  Mohammad Ali Farzin; Hassan Abdoos; Reza Saber
Journal:  Anal Bioanal Chem       Date:  2022-07-04       Impact factor: 4.478

10.  A CRISPR/Cas12a-assisted rapid detection platform by biosensing the apxIVA of Actinobacillus pleuropneumoniae.

Authors:  Tian Luan; Lu Wang; Jiyu Zhao; Hui Luan; Yueling Zhang; Chunlai Wang; Paul R Langford; Siguo Liu; Wanjiang Zhang; Gang Li
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.